Our scRNA-seq results showed that the gene expression of the Fos family and Jun family in the T2D group was down-regulated compared with the WT group, especially Fosb, which was also certificated by subsequent biological tests. The gene discussed is FOS; the disease is type 2 diabetes mellitus.